Evangelos J. Giamarellos-Bourboulis, George L Daikos, Panagiotis Gargalianos, Charalambos Gogos, Marios Lazanas, Periklis Panagopoulos, Garyphallia Poulakou, Helen Sambatakou, Michael Samarkos
Infectious Diseases and Therapy 2021 Sep;10(3):1081-1095
DOI: 10.1007/s40121-021-00471-1Download pdf 🡇
The study was funded by the Hellenic Institute for the Study of Sepsis. No Rapid Service Fee was received by the journal for the publication of this article.
Keywords: Azithromycin; COVID-19; Clarithromycin; Community-acquired pneumonia; Immunomodulation